Cargando…
Phenotypic Characterization of the c.1679+1643G>T (1811+1643G>T) Mutation in Hispanic Cystic Fibrosis Patients
Cystic fibrosis (CF) is the most common fatal genetic diseases in the United States in Caucasians. More than 2000 genetic mutations have been described and CF is now known to affect other races. The incidence of CF in individuals of Hispanic descent is estimated to be 1:9200. An uncommon mutation, 1...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068721/ https://www.ncbi.nlm.nih.gov/pubmed/29970830 http://dx.doi.org/10.3390/children5070091 |
_version_ | 1783343334703497216 |
---|---|
author | Fanous, Hani K. Delgado-Villata, Silvia Kovacs, Reka Shalaby-Rana, Eglal Sami-Zakahri, Iman |
author_facet | Fanous, Hani K. Delgado-Villata, Silvia Kovacs, Reka Shalaby-Rana, Eglal Sami-Zakahri, Iman |
author_sort | Fanous, Hani K. |
collection | PubMed |
description | Cystic fibrosis (CF) is the most common fatal genetic diseases in the United States in Caucasians. More than 2000 genetic mutations have been described and CF is now known to affect other races. The incidence of CF in individuals of Hispanic descent is estimated to be 1:9200. An uncommon mutation, 1811+1643G>T, was recently reported. We report four patients with the 1811+1643G>T mutation (homozygous or heterozygous) and describe their clinical features and compare them to the remainder of our Hispanic cohort group. The homozygous patients had a more severe phenotype compared to the Hispanic cohort in the following areas: their pancreatic status, forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC), chronic Pseudomonas aeruginosa (PA) colonization, pulmonary exacerbations requiring oral and intravenous antibiotics, and hospitalization rate. These preliminary findings suggest that future studies investigating the clinical trajectory with a larger cohort of patients homozygous for the 1811+1643G>T mutation are needed. |
format | Online Article Text |
id | pubmed-6068721 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60687212018-08-07 Phenotypic Characterization of the c.1679+1643G>T (1811+1643G>T) Mutation in Hispanic Cystic Fibrosis Patients Fanous, Hani K. Delgado-Villata, Silvia Kovacs, Reka Shalaby-Rana, Eglal Sami-Zakahri, Iman Children (Basel) Brief Report Cystic fibrosis (CF) is the most common fatal genetic diseases in the United States in Caucasians. More than 2000 genetic mutations have been described and CF is now known to affect other races. The incidence of CF in individuals of Hispanic descent is estimated to be 1:9200. An uncommon mutation, 1811+1643G>T, was recently reported. We report four patients with the 1811+1643G>T mutation (homozygous or heterozygous) and describe their clinical features and compare them to the remainder of our Hispanic cohort group. The homozygous patients had a more severe phenotype compared to the Hispanic cohort in the following areas: their pancreatic status, forced expiratory volume in 1 s (FEV1) and forced vital capacity (FVC), chronic Pseudomonas aeruginosa (PA) colonization, pulmonary exacerbations requiring oral and intravenous antibiotics, and hospitalization rate. These preliminary findings suggest that future studies investigating the clinical trajectory with a larger cohort of patients homozygous for the 1811+1643G>T mutation are needed. MDPI 2018-07-03 /pmc/articles/PMC6068721/ /pubmed/29970830 http://dx.doi.org/10.3390/children5070091 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Fanous, Hani K. Delgado-Villata, Silvia Kovacs, Reka Shalaby-Rana, Eglal Sami-Zakahri, Iman Phenotypic Characterization of the c.1679+1643G>T (1811+1643G>T) Mutation in Hispanic Cystic Fibrosis Patients |
title | Phenotypic Characterization of the c.1679+1643G>T (1811+1643G>T) Mutation in Hispanic Cystic Fibrosis Patients |
title_full | Phenotypic Characterization of the c.1679+1643G>T (1811+1643G>T) Mutation in Hispanic Cystic Fibrosis Patients |
title_fullStr | Phenotypic Characterization of the c.1679+1643G>T (1811+1643G>T) Mutation in Hispanic Cystic Fibrosis Patients |
title_full_unstemmed | Phenotypic Characterization of the c.1679+1643G>T (1811+1643G>T) Mutation in Hispanic Cystic Fibrosis Patients |
title_short | Phenotypic Characterization of the c.1679+1643G>T (1811+1643G>T) Mutation in Hispanic Cystic Fibrosis Patients |
title_sort | phenotypic characterization of the c.1679+1643g>t (1811+1643g>t) mutation in hispanic cystic fibrosis patients |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068721/ https://www.ncbi.nlm.nih.gov/pubmed/29970830 http://dx.doi.org/10.3390/children5070091 |
work_keys_str_mv | AT fanoushanik phenotypiccharacterizationofthec16791643gt18111643gtmutationinhispaniccysticfibrosispatients AT delgadovillatasilvia phenotypiccharacterizationofthec16791643gt18111643gtmutationinhispaniccysticfibrosispatients AT kovacsreka phenotypiccharacterizationofthec16791643gt18111643gtmutationinhispaniccysticfibrosispatients AT shalabyranaeglal phenotypiccharacterizationofthec16791643gt18111643gtmutationinhispaniccysticfibrosispatients AT samizakahriiman phenotypiccharacterizationofthec16791643gt18111643gtmutationinhispaniccysticfibrosispatients |